Amicus Therape…

Amicus Therapeutics (FOLD) stock price, revenue and financials

View Company

$1.9 B

FOLD Mkt cap, 04-Dec-2018
Amicus Therapeutics EBIT (Q3, 2018)-156.2 M
Amicus Therapeutics Cash, 30-Sep-2018201.8 M

Amicus Therapeutics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

363.0k1.2m5.0m36.9m

Revenue growth, %

(99%)(100%)

Cost of goods sold

833.0k6.2m

Gross profit

4.1m30.7m

Gross profit Margin, %

83%83%

R&D expense

41.9m76.9m104.8m149.3m

General and administrative expense

18.9m47.3m71.2m88.7m

Operating expense total

64.5m130.4m186.0m472.7m

Depreciation and amortization

1.7m1.8m3.2m3.6m

EBIT

(64.2m)(68.7m)(130.4m)(181.9m)(442.0m)

EBIT margin, %

(17681%)(5613%)(3669%)(1197%)

Interest expense

46.0k1.5m1.6m5.4m17.2m

Interest income

174.0k223.0k929.0k1.6m4.1m

Pre tax profit

(63.1m)(132.1m)(203.8m)(449.1m)

Income tax expense

3.5m1.1m1.1m3.7m165.1m

Net Income

(59.6m)(68.9m)(132.1m)(200.0m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

Revenue

39.0k456.0k475.0k293.0k456.0k475.0k293.0k

Cost of goods sold

344.0k775.0k1.8m

R&D expense

10.1m10.0m10.0m12.0m16.1m17.2m21.0m23.4m18.3m32.5m30.9m40.6m

General and administrative expense

4.6m5.2m4.8m5.3m6.4m8.3m15.4m15.7m19.3m17.5m19.1m21.6m

Operating expense total

15.2m16.1m14.7m17.1m24.1m26.9m38.0m43.0m48.5m46.7m55.4m284.3m

Depreciation and amortization

429.0k412.0k396.0k375.0k353.0k395.0k673.0k767.0k896.0k823.0k851.0k

EBIT

(15.1m)(15.6m)(14.3m)(16.8m)(24.1m)(26.9m)(38.0m)(43.0m)(48.5m)(44.9m)(52.0m)(275.2m)

EBIT margin, %

(38808%)(3426%)(3003%)(5739%)(5276%)(5672%)(12985%)

Interest expense

7.0k355.0k374.0k377.0k372.0k338.0k17.0k945.0k1.1m1.5m4.3m4.4m

Interest income

36.0k42.0k36.0k55.0k171.0k158.0k316.0k307.0k331.0k460.0k759.0k1.2m

Pre tax profit

(51.5m)(46.9m)(54.9m)(276.3m)

Income tax expense

453.0k253.0k(56.0k)164.7m

Net Income

(14.6m)(15.9m)(14.6m)(17.1m)(24.3m)(27.1m)(37.8m)(43.7m)(51.0m)(46.7m)(55.0m)(214.8m)

Amicus Therapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

43.6m24.1m69.5m187.0m49.1m

Accounts Receivable

1.3m9.5m

Inventories

5.5m2.9m2.6m3.4m4.6m

Current Assets

88.3m154.6m216.6m340.1m392.0m

Goodwill

11.6m11.6m197.8m197.8m197.8m

Total Assets

127.6m210.0m908.4m1.0b627.0m

Accounts Payable

10.2m16.3m32.2m185.5m

Short-term debt

Current Liabilities

10.5m20.2m73.6m111.0m70.0m

Long-term debt

Total Debt

Additional Paid-in Capital

423.6m568.7m917.5m1.1b1.4b

Retained Earnings

(447.4m)(579.6m)(779.6m)(1.1b)

Total Equity

45.8m122.2m347.8m360.2m352.9m

Financial Leverage

2.8 x1.7 x2.6 x2.9 x1.8 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

30.0m27.5m41.9m19.7m28.8m249.0m19.4m23.5m63.7m33.1m44.8m37.4m64.1m114.3m73.3m201.8m

Accounts Receivable

864.0k1.9m3.8m6.0m10.8m15.1m14.2m

Inventories

194.0k3.3m3.7m3.9m7.3m8.1m7.8m6.3m

Current Assets

64.3m73.5m79.4m87.2m151.3m365.0m240.1m168.5m217.7m221.7m296.2m241.0m431.0m592.0m576.2m601.0m

Goodwill

11.6m11.6m11.6m11.6m11.6m207.6m197.8m197.8m197.8m197.8m197.8m197.8m197.8m197.8m197.8m

Total Assets

69.1m112.4m118.0m125.5m192.6m403.9m986.7m862.9m914.0m918.2m993.4m939.0m680.8m870.0m825.9m838.6m

Accounts Payable

8.2m9.2m9.9m11.3m15.8m16.9m30.6m22.5m23.8m29.0m

Current Liabilities

8.6m9.4m11.2m13.8m21.0m16.9m35.9m64.4m80.5m85.6m109.6m100.7m68.2m140.7m53.0m65.9m

Total Liabilities

348.4m264.0m427.6m

Additional Paid-in Capital

392.2m424.8m444.6m468.7m574.8m826.6m914.3m921.2m990.0m1.0b1.1b1.1b1.4b1.6b1.7b1.7b

Retained Earnings

(409.1m)(426.2m)(471.7m)(498.9m)(536.7m)(623.3m)(674.3m)(721.0m)(834.6m)(882.7m)(994.4m)(1.1b)(1.2b)(1.3b)

Total Equity

26.5m31.1m36.3m43.3m104.0m328.9m378.8m311.6m334.2m336.6m310.8m266.9m409.7m521.6m561.9m411.0m

Financial Leverage

2.6 x3.6 x3.2 x2.9 x1.9 x1.2 x2.6 x2.8 x2.7 x2.7 x3.2 x3.5 x1.7 x1.7 x1.5 x2 x

Amicus Therapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(59.6m)(68.9m)(132.1m)(200.0m)(284.0m)

Depreciation and Amortization

1.7m1.5m1.8m3.2m3.6m

Accounts Receivable

(1.4m)(7.7m)

Inventories

(3.2m)2.3m308.0k(3.7m)(897.0k)

Accounts Payable

6.2m15.5m7.1m

Cash From Operating Activities

(45.8m)(51.7m)(100.1m)(150.5m)(215.5m)

Purchases of PP&E

(695.0k)(238.0k)(4.8m)(6.0m)(4.5m)

Cash From Investing Activities

(145.3m)(4.5m)(171.2m)

Cash From Financing Activities

139.2m290.9m272.7m247.4m

Interest Paid

30.0k1.2m605.0k3.0m7.4m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(47.4m)(15.9m)(30.6m)(47.7m)(24.3m)(51.4m)(89.2m)(43.7m)(94.7m)(141.4m)(55.0m)(103.1m)(214.8m)(49.9m)(111.8m)(270.9m)

Depreciation and Amortization

1.3m412.0k808.0k1.2m508.0k861.0k1.3m673.0k1.4m2.3m823.0k1.6m2.5m969.0k1.9m3.0m

Accounts Receivable

(863.0k)(512.0k)(2.2m)(4.3m)(1.0m)(6.0m)(5.2m)

Inventories

(207.0k)(3.5m)(243.0k)(351.0k)(3.4m)(3.3m)(3.4m)(2.0m)

Accounts Payable

(679.0k)(987.0k)(155.0k)1.2m(551.0k)459.0k14.1m(9.8m)(8.2m)(2.9m)(1.3m)

Cash From Operating Activities

(37.7m)(10.2m)(22.0m)(37.2m)(21.0m)(43.6m)(64.6m)(44.9m)(77.7m)(118.5m)(49.8m)(91.8m)(141.7m)(49.5m)(106.5m)(239.3m)

Purchases of PP&E

(645.0k)(40.0k)(132.0k)(192.0k)(753.0k)(1.4m)(2.2m)(2.9m)(4.6m)(5.5m)(732.0k)(2.3m)(3.4m)

Cash From Investing Activities

(5.8m)2.1m(27.3m)31.3m(230.7m)(39.9m)(92.4m)(48.9m)(222.8m)(182.6m)(171.9m)(57.4m)

Cash From Financing Activities

(85.0k)18.2m40.5m4.1m237.2m290.7m82.8m122.4m(95.0k)240.6m296.6m303.6m450.4m

Interest Paid

24.0k208.0k537.0k864.0k209.0k605.0k605.0k209.0k276.0k284.0k12.0k3.7m3.7m12.0k3.8m3.8m

Free Cash Flow

(50.3m)(108.4m)(243.8m)

Amicus Therapeutics Ratios

USDY, 2018

Financial Leverage

2 x
Download Excel
Report incorrect company information

Amicus Therapeutics Employee Rating

3.218 votes
Culture & Values
3.6
Work/Life Balance
3.5
Senior Management
3.3
Salary & Benefits
3.5
Career Opportunities
3.4
Source
View Amicus Therapeutics profile

Competitors

Sanofi Genzyme
Healthcare - Subsidiary
Mast Therapeutics
Healthcare - Public
Zogenix
Healthcare - Public
Clinigen Group
Healthcare - Public
Compare competitors